Workflow
中基健康(000972) - 2024 Q2 - 季度业绩预告
CHALKISCHALKIS(SZ:000972)2024-07-09 11:44

Financial Performance - The estimated net profit attributable to shareholders for the first half of 2024 is projected to be between 10 million and 15 million yuan, representing a decrease of 60.62% to 73.74% compared to the same period last year, which was 38.087 million yuan[6]. - The estimated net profit after deducting non-recurring gains and losses is expected to be between 2.5 million and 3.5 million yuan, reflecting a decline of 90.68% to 93.35% from 37.566 million yuan in the previous year[6]. - Basic earnings per share are projected to be between 0.013 yuan and 0.0194 yuan, down from 0.05 yuan per share in the same period last year[6]. Market Challenges - The decline in sales price and volume of the company's main product, bulk tomato sauce, is attributed to the impact of the Red Sea-Suez Canal shipping crisis, leading to extended delivery and payment cycles[7]. Strategic Development - The company is actively developing flagship products in the fast-moving consumer goods and health products sectors, with a focus on increasing domestic sales efforts and gradually improving domestic marketing channels[12].